Patient and carer experience of chimeric antigen receptor T-cell therapy: a multicentre qualitative study

The experience of CAR-T therapy is characterised by often unique symptom burden, uncertainty and resilience. It is vitally bolstered by the support of professionals and carers. There is evidence of missed opportunities to support patients and caregivers with the challenges of navigating an uncertain future, and 'parallel planning' conversations may be a way to meet this need. Future research should focus on the involvement of collaborative palliative/supportive care to support this patient group.